← Back to headlines
Novo's Wegovy to Be Accessible to 1.2 Million Additional Patients in England
Novo Nordisk's weight-loss drug, Wegovy, is set to become available to an additional 1.2 million patients across England.
1 Apr, 07:10 — 1 Apr, 07:10
Sources
Showing 1 of 1 sources
Related Stories
Enbridge Secures $2.7 Billion Investment for British Columbia Pipeline Expansion
19m ago
France Relaxes Cheese Production Rules Amid Severe Summer Drought
36m ago
Analysts Upgrade Price Targets for Nvidia and CrowdStrike Following Strong Earnings
50m ago
Fed Officials Outline Policy Priorities at Jackson Hole Ahead of Leadership Transition
54m ago